Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Brazilian Patent Office Confirms Refusal of Tenofovir Patent Application
Opponents in pre-grant oppositions to be given access to responses by patent applicants
USPTO Confirms Gilead’s Remanining Patents for Tenofovir as Valid
US, Indian HIV/AIDS Drug Rulings Could Reverberate In Brazil – By Tatum Anderson of IP Watch
US, Indian HIV/AIDS Drug Rulings Could Reverberate In Brazil
Brazilian Patient Group Joins With Indian Group to Challenge Tenofovir Patent in India
Delhi Patent Office Refuses Patent on Pediatric Aids Drug Nevirapine Hemiydrate
USPTO Confirms the Validity of a Second Tenofovir Patent
Gilead Announces that USPTO to Uphold One of the Viread Patents
Tenofovir Patent Takes Another Hit